Literature DB >> 26536043

Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment.

Michael J Hassett1,2, Maria J Schymura3, Kun Chen1, Francis P Boscoe3, Foster C Gesten4, Deborah Schrag1,2.   

Abstract

BACKGROUND: Racial/ethnic and socioeconomic disparities persist in part because our current understanding of the care provided to minority and disadvantaged populations is limited. The authors evaluated the quality of breast cancer care in 2 large states to understand the disparities experienced by African Americans, Hispanics, Asian/Pacific Islanders (APIs), and Medicaid enrollees and to prioritize remediation strategies.
METHODS: Statewide cancer registry data for 80,436 women in New York and 121,233 women in California who were diagnosed during 2004 to 2009 with stage 0 through III breast cancer were used to assess underuse and overuse of surgery, radiation, chemotherapy, and hormone therapy based on 34 quality measures. Concordance values were compared across racial/ethnic and Medicaid-enrollment groups. Multivariable models were used to quantify disparities across groups for each treatment in each state.
RESULTS: Overall concordance was 76% for underuse measures and 87% for overuse measures. The proportions of patients who received care concordant with all relevant measures were 35% in New York and 33% in California. Compared with whites, African Americans were less likely to receive recommended surgery, radiation, and hormone therapy; Hispanics and APIs were usually more likely to receive recommended chemotherapy. Across states, the same racial/ethnic groups did not always experience the same disparities. Medicaid enrollment was associated with decreased likelihood of receiving all recommended treatments, except chemotherapy, in both states. Overuse was evident for hormone therapy and axillary surgery but was not associated with race/ethnicity or Medicaid enrollment.
CONCLUSIONS: Patient-level measures of quality identify substantial problems with care quality and meaningful disparities. Remediating these problems will require prioritizing low-performing measures and targeting high-risk populations, possibly in different ways for different regions.
© 2015 American Cancer Society.

Entities:  

Keywords:  Medicaid; breast cancer; disparities; quality

Mesh:

Year:  2015        PMID: 26536043      PMCID: PMC4724235          DOI: 10.1002/cncr.29777

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  34 in total

1.  Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer.

Authors:  Rachel L Yung; Michael J Hassett; Kun Chen; Foster C Gesten; Patrick J Roohan; Francis P Boscoe; Amber H Sinclair; Maria J Schymura; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2012-07-06       Impact factor: 13.506

2.  Quality measures and sociodemographic risk factors: to adjust or not to adjust.

Authors:  Kevin Fiscella; Helen R Burstin; David R Nerenz
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

3.  Adjuvant therapy for breast cancer: practice patterns of community physicians.

Authors:  Linda C Harlan; Jeffrey Abrams; Joan L Warren; Lin Clegg; Jennifer Stevens; Rachel Ballard-Barbash
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

4.  Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study.

Authors:  Robert R German; Jennifer M Wike; Katrina R Bauer; Steven T Fleming; Amy Trentham-Dietz; Mary Namiak; Lyn Almon; Karen Knight; Carin Perkins
Journal:  J Registry Manag       Date:  2011

5.  Completeness of American Cancer Registry Treatment Data: implications for quality of care research.

Authors:  Katherine Mallin; Bryan E Palis; Nancy Watroba; Andrew K Stewart; Daniel Walczak; Joseph Singer; John Barron; Wendy Blumenthal; Georgette Haydu; Stephen B Edge
Journal:  J Am Coll Surg       Date:  2013-01-26       Impact factor: 6.113

6.  Impact of care at comprehensive cancer centers on outcome: Results from a population-based study.

Authors:  Julie A Wolfson; Can-Lan Sun; Laura P Wyatt; Arti Hurria; Smita Bhatia
Journal:  Cancer       Date:  2015-07-28       Impact factor: 6.860

7.  Characteristics associated with differences in survival among black and white women with breast cancer.

Authors:  Jeffrey H Silber; Paul R Rosenbaum; Amy S Clark; Bruce J Giantonio; Richard N Ross; Yun Teng; Min Wang; Bijan A Niknam; Justin M Ludwig; Wei Wang; Orit Even-Shoshan; Kevin R Fox
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

8.  Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry.

Authors:  Abigail Silva; Garth H Rauscher; Carol Estwing Ferrans; Kent Hoskins; Ruta Rao
Journal:  J Registry Manag       Date:  2014

9.  Combining multiple indicators of clinical quality: an evaluation of different analytic approaches.

Authors:  David Reeves; Stephen M Campbell; John Adams; Paul G Shekelle; Evan Kontopantelis; Martin O Roland
Journal:  Med Care       Date:  2007-06       Impact factor: 2.983

10.  Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.

Authors:  E C Inwald; M Koller; M Klinkhammer-Schalke; F Zeman; F Hofstädter; P Lindberg; M Gerstenhauer; S Schüler; O Treeck; O Ortmann
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-08       Impact factor: 4.553

View more
  13 in total

1.  Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.

Authors:  Justin G Trogdon; Donatus U Ekwueme; Diana Poehler; Cheryll C Thomas; Katherine Reeder-Hayes; Benjamin T Allaire
Journal:  Breast Cancer Res Treat       Date:  2017-07-12       Impact factor: 4.872

2.  Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.

Authors:  Vanessa B Sheppard; Luciane R Cavalli; Chiranjeev Dash; Yasmine M Kanaan; Asma A Dilawari; Sara Horton; Kepher H Makambi
Journal:  Clin Breast Cancer       Date:  2017-01-06       Impact factor: 3.225

3.  Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists.

Authors:  Susan Eggly; Lauren M Hamel; Tanina S Foster; Terrance L Albrecht; Robert Chapman; Felicity W K Harper; Hayley Thompson; Jennifer J Griggs; Richard Gonzalez; Lisa Berry-Bobovski; Rifky Tkatch; Michael Simon; Anthony Shields; Shirish Gadgeel; Randa Loutfi; Haythem Ali; Ira Wollner; Louis A Penner
Journal:  Patient Educ Couns       Date:  2016-12-27

4.  Veterans' Reliance on VA Care by Type of Service and Distance to VA for Nonelderly VA-Medicaid Dual Enrollees.

Authors:  Jean Yoon; Megan E Vanneman; Sharon K Dally; Amal N Trivedi; Ciaran S Phibbs
Journal:  Med Care       Date:  2019-03       Impact factor: 2.983

5.  Breast Cancer Incidence and Mortality by Molecular Subtype: Statewide Age and Racial/Ethnic Disparities in New Jersey.

Authors:  Aishwarya Kulkarni; Antoinette M Stroup; Lisa E Paddock; Stephanie M Hill; Jesse J Plascak; Adana A M Llanos
Journal:  Cancer Health Disparities       Date:  2019-08-19

6.  The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions.

Authors:  Louis A Penner; John F Dovidio; Richard Gonzalez; Terrance L Albrecht; Robert Chapman; Tanina Foster; Felicity W K Harper; Nao Hagiwara; Lauren M Hamel; Anthony F Shields; Shirish Gadgeel; Michael S Simon; Jennifer J Griggs; Susan Eggly
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

Review 7.  Racial/Ethnic Disparities in Neonatal Intensive Care: A Systematic Review.

Authors:  Krista Sigurdson; Briana Mitchell; Jessica Liu; Christine Morton; Jeffrey B Gould; Henry C Lee; Nicole Capdarest-Arest; Jochen Profit
Journal:  Pediatrics       Date:  2019-08       Impact factor: 7.124

8.  Relationship between Insurance Type at Diagnosis and Hepatocellular Carcinoma Survival.

Authors:  Shoshana Adler Jaffe; Orrin Myers; Angela L W Meisner; Charles L Wiggins; Deirdre A Hill; Jean A McDougall
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-03       Impact factor: 4.254

9.  Physician peer group characteristics and timeliness of breast cancer surgery.

Authors:  Jacqueline Bachand; Pamela R Soulos; Jeph Herrin; Craig E Pollack; Xiao Xu; Xiaomei Ma; Cary P Gross
Journal:  Breast Cancer Res Treat       Date:  2018-04-24       Impact factor: 4.872

10.  Development and Evaluation of a Process to Link Cancer Patients in the SEER Registries to National Medicaid Enrollment Data.

Authors:  Joan L Warren; Suzie Benner; Jennifer Stevens; Lindsey Enewold; Bin Huang; Lirong Zhao; Negussie Tilahun; Cathy J Bradley
Journal:  J Natl Cancer Inst Monogr       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.